Johnson & Johnson, which manufactured generic opioid medications, will pay $5 billion in the settlement, and three drug wholesalers — AmerisourceBergen, Cardinal Health and McKesson – will pay a combined $21 billion, according to the Feb. 25 NPR report.
The settlement resolves thousands of civil lawsuits filed since 2014 by local and state governments, as well as Native American tribes nationwide.
In a Feb. 25 statement from Johnson & Johnson, the corporation said its contribution to the settlement would “directly support state and local efforts to make meaningful progress in addressing the opioid crisis.”
Initial payments will begin in April and continue for two decades.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
